(Q42664779)

4 November 2017

title

Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients (English)

1 reference

4 November 2017

1 reference

fluticasone propionate

1 reference

T B Casale

1

1 reference

4 November 2017

H S Nelson

2

1 reference

4 November 2017

W E Stricker

3

1 reference

4 November 2017

H Raff

4

1 reference

4 November 2017

K B Newman

5

1 reference

4 November 2017

publication date

1 November 2001

1 reference

Annals of Allergy, Asthma & Immunology

4 November 2017

published in

1 reference

4 November 2017

volume

87

1 reference

4 November 2017

issue

5

1 reference

4 November 2017

page(s)

379-385

1 reference

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Pharmacological factors that influence the choice of inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Dose-response of inhaled drugs in asthma. An update

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Pharmacokinetics of intravenous fluticasone propionate in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Pharmacokinetic/Pharmacodynamic Evaluation of Systemic Effects of Flunisolide after Inhalation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

Salivary Cortisol: A Better Measure of Adrenal Cortical Function than Serum Cortisol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962918-3

7 January 2021

10.1016/S1081-1206(10)62918-3

Identifiers

DOI

1 reference

4 November 2017

1 reference